Unveiling the True Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Is Coronary Artery Calcium Scoring with Treatment the Right Approach?
作者信息
Zeng Xiangxia
机构信息
Department of Nutrition, School of Public Health and The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
出版信息
Am J Respir Crit Care Med. 2025 Aug;211(8):1527-1528. doi: 10.1164/rccm.202502-0425LE.
Abstract
摘要
相似文献
1
Unveiling the True Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Is Coronary Artery Calcium Scoring with Treatment the Right Approach?揭示慢性阻塞性肺疾病中的真正心血管风险：治疗时进行冠状动脉钙化评分是正确的方法吗？
Am J Respir Crit Care Med. 2025 Aug;211(8):1527-1528. doi: 10.1164/rccm.202502-0425LE.
2
Reply to Zeng: Unveiling the True Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Is Coronary Artery Calcium Score Assessment the Right Approach?对曾的回复：揭示慢性阻塞性肺疾病中真正的心血管风险：冠状动脉钙化评分评估是正确的方法吗？
Am J Respir Crit Care Med. 2025 Aug;211(8):1528-1529. doi: 10.1164/rccm.202503-0546LE.
3
Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational Study.慢性阻塞性肺疾病中经放射学检测的冠状动脉疾病的患病率及其临床关联：一项横断面观察性研究。
Am J Respir Crit Care Med. 2025 Jun;211(6):946-956. doi: 10.1164/rccm.202404-0838OC.
4
Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.2 型糖尿病患者的冠状动脉钙、肝脂肪变性和动脉粥样硬化性心血管疾病风险：达拉斯心脏研究的结果。
Prog Cardiovasc Dis. 2023 May-Jun;78:67-73. doi: 10.1016/j.pcad.2023.03.002. Epub 2023 Mar 15.
5
The zero calcium score paradox and multivessel obstructive disease: a case report of a patient with zero CAC score.零钙评分悖论与多支血管阻塞性疾病：一例钙冠状动脉钙化（CAC）评分为零患者的病例报告
Am J Cardiovasc Dis. 2025 Jun 15;15(3):175-180. doi: 10.62347/GLVD7571. eCollection 2025.
6
Association Between Lipoprotein(a) and Obstructive Coronary Artery Disease and High-Risk Plaque: Insights From the PROMISE Trial.载脂蛋白(a)与阻塞性冠状动脉疾病和高危斑块的相关性：来自 PROMISE 试验的见解。
Am J Cardiol. 2024 Nov 15;231:40-47. doi: 10.1016/j.amjcard.2024.09.006. Epub 2024 Sep 6.
7
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).用于预防和治疗慢性肾脏病-矿物质和骨异常（CKD-MBD）的磷结合剂。
Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3.
8
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).用于预防和治疗慢性肾脏病-矿物质和骨异常（CKD-MBD）的磷结合剂。
Cochrane Database Syst Rev. 2025 Jun 27;6(6):CD006023. doi: 10.1002/14651858.CD006023.pub4.
9
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.非酒精性脂肪性肝病生物标志物基于冠状动脉钙评分估计 2 型糖尿病患者的心血管风险：两项独立队列的横断面研究。
Cardiovasc Diabetol. 2024 Feb 13;23(1):69. doi: 10.1186/s12933-024-02161-x.
10
Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis.冠状动脉钙化密度与心血管事件风险：一项系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2025 Mar;18(3):294-304. doi: 10.1016/j.jcmg.2024.07.024. Epub 2024 Sep 4.
本文引用的文献
1
Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational Study.慢性阻塞性肺疾病中经放射学检测的冠状动脉疾病的患病率及其临床关联：一项横断面观察性研究。
Am J Respir Crit Care Med. 2025 Jun;211(6):946-956. doi: 10.1164/rccm.202404-0838OC.
2
Sex and Gender Bias as a Mechanistic Determinant of Cardiovascular Disease Outcomes.作为心血管疾病结局机制决定因素的性别与性别的偏差
Can J Cardiol. 2022 Dec;38(12):1865-1880. doi: 10.1016/j.cjca.2022.09.009. Epub 2022 Sep 15.
3
Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET.疾病进展和年龄是 COPD 患者共病的基础因素：COSYCONET 的结果。
Int J Chron Obstruct Pulmon Dis. 2022 Jul 29;17:1703-1713. doi: 10.2147/COPD.S364812. eCollection 2022.
4
Dietary Habits of Patients with Coronary Artery Disease: A Case-Control Study from Pakistan.冠心病患者的饮食习惯：来自巴基斯坦的病例对照研究。
Int J Environ Res Public Health. 2022 Jul 15;19(14):8635. doi: 10.3390/ijerph19148635.
5
The burden of major adverse cardiac events in patients with coronary artery disease.冠状动脉疾病患者主要不良心脏事件的负担
BMC Cardiovasc Disord. 2017 Jan 4;17(1):1. doi: 10.1186/s12872-016-0436-7.
6
Effect of occupational exposure to lead on new risk factors for cardiovascular diseases.职业性铅暴露对心血管疾病新危险因素的影响。
Occup Environ Med. 2017 May;74(5):366-373. doi: 10.1136/oemed-2016-103996. Epub 2016 Dec 16.
7
Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry.在接受冠状动脉计算机断层扫描血管造影术的无症状冠状动脉钙化评分为零的患者中，冠状动脉疾病的患病率和严重程度以及不良事件：来自 CONFIRM（冠状动脉 CT 血管造影评估临床结果：国际多中心）注册研究的结果。
J Am Coll Cardiol. 2011 Dec 6;58(24):2533-40. doi: 10.1016/j.jacc.2011.10.851. Epub 2011 Nov 9.
8
Significance of coronary artery calcification score (CACS) for the detection of coronary artery disease (CAD) in chronic dialysis patients.冠状动脉钙化评分（CACS）在慢性透析患者冠状动脉疾病（CAD）检测中的意义。
Clin Chim Acta. 2006 May;367(1-2):98-102. doi: 10.1016/j.cca.2005.11.028. Epub 2006 Jan 18.
Zotero 插件